FDA Alerts

Drug Therapy
Drug Therapy
FDA Approves New Drug for AML Subtype
09/01/2017
The US Food and Drug Administration has approved a new treatment option for adult and pediatric patients with CD33-positive acute myeloid leukemia.
09/01/2017
Drug Therapy
Drug Therapy
FDA Approves New Treatment for Tardive Dyskinesia
09/01/2017
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved a new option for adult patients with tardive dyskinesia.
09/01/2017
FDA
FDA
FDA Approves First Gene Therapy in the US
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017
FDA
FDA
FDA Approves New Antibacterial Drug
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
FDA Approves First US Treatment for Chagas Disease
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017
Diabetes Q&A
Diabetes Q&A
FDA Expands Indication for Victoza
08/28/2017
The US Food and Drug administration expanded the indication for Victoza, a GLP-1 analog originally approved in 2010.
08/28/2017
Breast cancer
Breast cancer
FDA Expands Approval of Faslodex
08/28/2017
The US Food and Drug Administration has expanded the approval of Faslodex, a hormonal therapy for the treatment of breast cancer first approved in 2002.
08/28/2017
Parkinson Disease
Parkinson Disease
FDA Approves First Treatment for Therapy-Induced Dyskinesia
08/25/2017
The FDA has approved the first and only treatment option for levodopa-induced dyskinesia in patients with Parkinson disease.
08/25/2017
Gout
Gout
FDA Approves New Option for Hyperuricemia Associated with Gout
08/21/2017
After clinical trials demonstrated its safety and efficacy, the FDA approved a new treatment that is the first to combine standard care with a new therapy for adult patients with hyperuricemia associated...
08/21/2017